Overview
- Peptide (C)GTPAFSPTPERPQPT, corresponding to amino acid residues 53 - 67 of mouse TMEM119 (Accession Q8R138). Extracellular, N-term.
- Cell surface detection of TMEM119 by direct flow cytometry in live intact mouse BV-2 microglia cells:___ Cells.
___ Cells + Rabbit IgG isotype control-APC.
___ Cells + Anti-TMEM119 (extracellular)-APC Antibody (#ANR-175-APC), (2.5µg) . - Cell surface detection of TMEM119 by direct flow cytometry in live intact mouse SIM-A9 microglia cells:___ Cells.
___ Cells + Rabbit IgG isotype control-APC (#RIC-001-APC).
___ Cells + Anti-TMEM119 (extracellular)-APC Antibody (#ANR-175-APC), (5µg).
Transmembrane protein 119, Tmem119, is a bone formation related factor that belongs to a group of bone morphogenetic proteins (BMPs). It is a class IA single pass transmembrane protein1.
Tmem119 promotes the differentiation of myoblasts (embryonic precursors of muscle cells) into osteoblasts and plays a role in numerous BMP signaling pathways1,2.
Tmem119 is uniquely expressed in microglia cells and it is therefore used as a microglia-specific homeostatic marker that can assist in differentiating microglia cells from peripherally derived macrophages in the brain3. This marker is very important for diagnosing CNS disease: monocytes/macrophages are key cellular modulators of brain homeostasis. In the healthy brain resident microglia are the predominant macrophage cell population but when the blood-brain barrier is leaking peripheral monocytes/macrophages can infiltrate the brain and participate in CNS disease pathogenesis. Distinguishing these two monocytes/macrophages populations is often challenging and hence the existence of a highly expressed and robust microglia marker such as Tmem119 is very important4.